 Home > Chemicals Industry > China Chemical > In the first half of the year, the pharmaceutical equipment industry has mixed good and bad news. Can it come back against the wind in the second half?

In the first half of the year, the pharmaceutical equipment industry has mixed good and bad news. Can it come back against the wind in the second half?

 Last Update: 2022-06-09
 Source: Internet
 Author: User

Tags

kevlar chemical formula

american chemical technologies

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

[ Focus on Chemical Machinery and Equipment Network ] At the beginning of 2020, due to the impact of a special period, all walks of life will inevitably be impacted.
As far as the pharmaceutical equipment industry is concerned, in the first quarter, many companies were delayed due to downstream companies' resumption of work and production, and the progress of equipment delivery and commissioning slowed down, and sales revenue in the current period decreased.
However, as the domestic situation is gradually brought under control, pharmaceutical companies have continued to expand their demand for capacity enhancement, and with the development of online office by pharmaceutical machine companies, some companies have seized the opportunity and ushered in growth.

Chemical machinery and equipment network hotspots pay attention to chemical machinery and equipment

The semi-annual reports of pharmaceutical machinery companies have been released one after another, and the first half of the year has been mixed

At present, the performance reports of major listed companies in the first half of the year have been disclosed one after another.
The author selected three representative listed companies to explore the survival conditions of pharmaceutical companies in this slightly special first half of the year.

From the perspective of revenue, the total revenue of the three pharmaceutical machinery companies in the first half of the year exceeded 2.
3 billion yuan.
Compared with the revenue of 1.
405 billion yuan in the first half of 2019, it showed a significant increase, which also shows that the pharmaceutical machinery company in the first half of this year The industry gains opportunities, and the strong will remain strong.

　　In the first half of the year, Tofflon and Canaan Technology both showed a revenue growth trend, increasing by 28.
41% and 76.
38% year-on-year respectively.
Chutian's revenue in the first half of the year fell by 9.
14% year-on-year.

　　From the perspective of net profit, the total net profit of the three pharmaceutical machinery companies in the first half of the year exceeded 500 million yuan, which has also increased compared with the total revenue of 400 million yuan in the first half of 2019.

　　The net profit growth of the three pharmaceutical machinery companies is relatively distinct.
Among them, Tofflon achieved a net profit of 172 million yuan (the same below) in the first half of the year, a year-on-year increase of 350.
16%.
Canaan Technology achieved a net profit of 28.
2 million yuan, an increase of 55.
21% year-on-year, and the difference between the two increases by more than 6 times.
However, Chutian's net profit dropped by 62.
82% year-on-year.

　　Regarding the reasons for both the increase in revenue and net profit, Tofflon explained in the announcement that during the reporting period, the company actively guaranteed and promoted the preset domestic project delivery plan, always paid attention to the progress of the project, and maintained effective online methods with customers.
Communicate and respond quickly to customer needs.
The company continues to implement the concept of precise management and implements digital transformation.
The proportion of material costs and expenses in operating income has decreased compared with the same period of the previous year.
In addition, Tofflon also focuses on the development strategy of "systematization, digitization" to provide drug manufacturing model research and pharmaceutical equipment development for drug research and development and industrial upgrading.

　　Canaan Technology said that the main reason is that the company is working together to actively take various effective measures to respond to the epidemic, and make every effort to guarantee the supply of products related to the epidemic in pharmaceutical companies and the logistics industry for some downstream customers.
The company's sales have grown steadily while operating efficiency has improved, ensuring steady growth in operating performance.

　　Although Chutian Technology's operating performance declined in the first half of the year, the company stated that it has continued to increase its investment in R&D, core manufacturing capabilities and quality assurance capabilities.
Chutian’s core competitiveness and brand influence have further improved, and the market situation is welcome.
Here comes a new breakthrough.

　　Generally speaking, in the first half of the year, some people in pharmaceutical machinery companies were happy and some were worried.
As my country's pharmaceutical equipment industry is dominated by small and medium-sized companies, small and medium-sized companies may be relatively less competitive compared with large-scale companies, and their performance will also face certain pressures in special periods.

　　In the second half of the year, can the industry come back against the wind?

　　At present, the pharmaceutical equipment industry as a whole is showing a trend of recovery.
The industry expects that the domestic pharmaceutical equipment industry will usher in geometric growth in the second half of the year, while challenges and opportunities coexist.

　　In terms of opportunities, under the influence of policies such as the third batch of centralized procurement, consistency evaluation, and new medical insurance negotiations, the pharmaceutical industry is facing upgrading and transformation, and the demand for pharmaceutical products is expected to increase, driving the development of the pharmaceutical equipment market.

　　In terms of challenges, pharmaceutical companies will go from pursuing low-end and low-level to high-precision technology and chemical equipment.
However, at present, the problems of insufficient domestic equipment and lack of high-tech pharmaceutical equipment manufacturers have become prominent, which has become a "blocker" for domestic pharmaceutical equipment to enter the market and urgently need to be tackled.

Pharmaceutical equipment

　　Aiming at the field, it has made frequent actions in recent years.
For example, Canaan Technology decided to invest abroad this year to establish a wholly-owned subsidiary as the company’s future project expansion or new project reserve land.
Relying on this industrial base, it will continue to strengthen the business of generic drug solid preparation smart factories, The core competitiveness of the three major business sectors of innovative medical water equipment and pharmaceutical liquid dispensing system engineering business and smart logistics business is to build a supporting data operation center; at the same time, it further expands the company’s business scale and builds a talent training base and pharmaceutical equipment, A research and development base for high-tech achievements in the field of intelligent logistics, comprehensively enhance the technical level and comprehensive competitiveness of the company's core products.

　　No *Coincidentally, Chutian is building a new model project for the intelligent manufacturing of biomedical robots and equipment.
In recent years, it has gradually built a technology and product line platform such as an intelligent aseptic packaging technology product line, an intelligent system integration and a special packaging technology product line.
Create an overall technical solution for intelligent pharmaceutical production, improve the intelligent level of pharmaceutical production, and provide a higher level of guarantee for the quality and safety of pharmaceutical production.

　　In order to help the development of the domestic pharmaceutical machinery industry, * and other four departments have jointly issued the "Guiding Opinions on Expanding Investment in Strategic Emerging Industries, Cultivating and Growing New Growth Pole Growth Pole", which proposes to speed up the equipment manufacturing industry to make up for shortcomings.
Focus on supporting the production of equipment such as medical equipment and pharmaceutical equipment, and implement pilot demonstrations of smart manufacturing and smart construction.
With the release of this opinion, the industry believes that it will promote the development of the domestic pharmaceutical machinery industry in the direction of transformation.

　　Concluding remarks

　　In general, due to the increasing aging of the population, the increase in the number of patients with chronic diseases, and the increase in consumption levels, the demand for medicines will continue to expand.
The industry predicts that by 2025, the overall scale of my country's biopharmaceutical market will reach 833.
2 billion yuan.
This will also drive the development of the pharmaceutical equipment market.
In the first half of this year, due to the impact of a special period, although some pharmaceutical machinery companies have been impacted, it should also be noted that domestic pharmaceutical machinery is ushering in the support of favorable policies.
Companies targeting the market may be expected to open up new paths and reform in the pharmaceutical industry.
Ushered in a new growth point.

　　Original title: The pharmaceutical equipment industry in 2020: The first half of the year is mixed.
Can the second half of the year come back against the wind?

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.